| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/30/2009 | WO2009157575A1 Skin preparation for external use, whitening agent, anti-aging agent, and antioxidant |
| 12/30/2009 | WO2009157418A1 Carboxylic acid compound |
| 12/30/2009 | WO2009156859A1 Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives |
| 12/30/2009 | WO2009156691A2 Novel inverse latices that are free of oxyethylene derivatives, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same |
| 12/30/2009 | WO2009156690A2 Novel inverse latices based on fatty alcohol ethers, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same |
| 12/30/2009 | WO2009156679A1 Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
| 12/30/2009 | WO2009156677A2 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative |
| 12/30/2009 | WO2009156675A2 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid |
| 12/30/2009 | WO2009155730A1 A pharmaceutical composition for treating disease caused by immune disturbance and the extract from tuckahoe |
| 12/30/2009 | WO2009155689A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections |
| 12/30/2009 | WO2009117831A9 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties |
| 12/30/2009 | EP2138495A1 Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives |
| 12/30/2009 | EP2138484A1 Fused bicyclic heteroaryl derivatives |
| 12/30/2009 | EP2138170A2 Prevention and Treatment of Oxidative Stress Disorders by compounds which elevate intracellular levels of glutathione or Phase II Detoxification Enzymes |
| 12/30/2009 | EP2138159A1 Whitening agent |
| 12/30/2009 | EP2137141A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 12/30/2009 | EP2136828A1 Pharmaceutical composition with antifungal activity containing cymbopogon nardus, its process, and use |
| 12/30/2009 | EP2136819A1 Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same |
| 12/30/2009 | EP2049525B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 12/30/2009 | EP1763343B1 Calcium trifluoroacetate for preparing antiangiogenetic medicaments |
| 12/30/2009 | EP1509597B1 Method for isolating hair follicle mesenchymal stem cells |
| 12/30/2009 | EP1487444B1 Use of pyridyl amides as inhibitors of angiogenesis |
| 12/30/2009 | CN201372259Y Manufacturing system extracting chitosan of antibiotic peptide substance from maggots |
| 12/30/2009 | CN201370888Y Multifunctional medicated pad |
| 12/30/2009 | CN101612402A Interferon antagonist and use of Flt3L interferon |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |
| 12/30/2009 | CN100575335C Amino-propanol derivatives |
| 12/30/2009 | CN100574794C Traditional Chinese medicine composition for delaying skin senility |
| 12/30/2009 | CN100574789C External Chinese traditional medicine for accelerating wound healing, reducing cicatrisation, and preparation method |
| 12/30/2009 | CN100574779C Compound oil for treating empyrosis and skin infection and method for preparation thereof |
| 12/30/2009 | CN100574778C Acne treating compound Chinese medicine preparation |
| 12/30/2009 | CN100574776C Outer applying liquid for treating burn and scald, and preparation method |
| 12/30/2009 | CN100574769C Nerve growth factor production inhibitor and external preparation for skin, cosmetic, quasi medicine, itch prophylactic and therapeutic agent and atopic dermatitis therapeutic agent |
| 12/30/2009 | CN100574767C Composition for preventing mammmal vagina infection and use |
| 12/30/2009 | CN100574744C Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetic composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement |
| 12/30/2009 | CN100574743C 抗老化剂 Anti-aging agents |
| 12/30/2009 | CN100574739C External preparations for skin |
| 12/30/2009 | CA2728694A1 Substituted pyrimidone derivatives |
| 12/30/2009 | CA2728693A1 Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives |
| 12/30/2009 | CA2728112A1 Pharmaceutical composition and extract of poria for treating a disease induced from immune disorder |
| 12/30/2009 | CA2727340A1 Carboxylic acid compound |
| 12/30/2009 | CA2726996A1 Method and compositions for improving skin and body appearance |
| 12/30/2009 | CA2723435A1 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid |
| 12/30/2009 | CA2723342A1 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative |
| 12/30/2009 | CA2723313A1 Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
| 12/29/2009 | USRE41065 Such as (6,7-dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine for treatment of hyperproliferative diseases |
| 12/29/2009 | US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/29/2009 | US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 12/29/2009 | US7638546 Imidazolyl derivatives |
| 12/29/2009 | US7638529 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 12/29/2009 | US7638523 e.g. tert-butyl 2-(4-(2-(4-(2-(diethylamino)ethoxy)phenylamino)pyrimidin-5-yl)-2-fluorobenzamido)acetate; C-kit kinase receptor or stem cell factor inhibitors; asthma allergic sinusitis and rhinitis, atopic and allergic dermatitis, allergic contact rheumatoid arthritis, multiple sclerosis, lupus etc. |
| 12/29/2009 | US7638518 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 12/29/2009 | US7638494 G-type peptides to ameliorate atherosclerosis |
| 12/29/2009 | US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 12/29/2009 | US7638149 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 12/29/2009 | US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine |
| 12/29/2009 | CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/29/2009 | CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 12/29/2009 | CA2465349C Transdermal drug for the treatment of neural paralysis and dysfunction |
| 12/29/2009 | CA2451932C Pyrrolopyrimidines as protein kinase inhibitors |
| 12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
| 12/29/2009 | CA2423296C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 12/29/2009 | CA2415683C Indoloquinazolinones |
| 12/29/2009 | CA2411058C Skin treatment using a new retinoid |
| 12/29/2009 | CA2387013C 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions |
| 12/29/2009 | CA2335663C Cosmetic and pharmaceutical oil-in-water emulsions |
| 12/24/2009 | US20090318570 Skin protection compositions, in particular cream to protect against cold |
| 12/24/2009 | US20090318534 Methods and compositions for the treatment of skin diseases and disorders |
| 12/24/2009 | US20090318452 INHIBITORS OF p38 |
| 12/24/2009 | US20090318449 Therapeutic lactams |
| 12/24/2009 | US20090318371 Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (microsponged benzoyl peroxide) |
| 12/24/2009 | US20090318355 Administering to one or more malignant cells an effective amount of a peptide species comprising an E-domain of insulin-like growth factor I (IGF-I); cancer |
| 12/24/2009 | US20090318352 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins |
| 12/24/2009 | US20090317485 Skin Protectant Spray Compositions |
| 12/24/2009 | US20090317483 Bicomponent Bioadhesive for Biomedical Use |
| 12/24/2009 | US20090317467 Hydrocolloid composition |
| 12/24/2009 | US20090317439 Cell Preparations for Extemporaneous Use, Useful for Healing and Rejuvenation In Vivo |
| 12/24/2009 | US20090317431 Peeling capsules |
| 12/24/2009 | US20090317429 Aloe vera cotton swab tips |
| 12/24/2009 | US20090317400 Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof |
| 12/24/2009 | US20090317389 Fusion molecules and methods for treatment of immune diseases |
| 12/24/2009 | US20090317370 Methods And Means For Protecting The Skin Against Pathogenic Microorganisms |
| 12/24/2009 | US20090317367 Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells |
| 12/24/2009 | US20090317354 Composition for restoring damaged skin comprising a saccaride and povidone-iodine |
| 12/24/2009 | US20090317338 Foamable iodine compositions |
| 12/23/2009 | WO2009155334A1 Differentiation of mesenchymal stem cells into fibroblasts, compositions comprising mesenchymal stem cell-derived fibroblasts, and methods of using the same |
| 12/23/2009 | WO2009155070A2 Compositions and methods for treatment of inflammation and hyperkeratotic lesions |
| 12/23/2009 | WO2009154396A2 Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release |
| 12/23/2009 | WO2009154237A1 Stabilizer for lymph vessel |
| 12/23/2009 | WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 12/23/2009 | WO2009154147A1 Oxybuprocaine-containing analgesic/antipruritic preparation for external application |
| 12/23/2009 | WO2009154014A1 External composition |
| 12/23/2009 | WO2009153459A1 Combination of a tiliroside and a peptide |
| 12/23/2009 | WO2009152735A1 Histone deacetylase inhibitors and uses thereof |
| 12/23/2009 | WO2009114139A3 Methods, compositions, and kits for treating pain and pruritis |
| 12/23/2009 | WO2009060186A8 Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias |
| 12/23/2009 | WO2009020534A3 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
| 12/23/2009 | WO2009000875A3 Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis |
| 12/23/2009 | WO2008037937A3 Use of compounds of the milbemycin family for the treatment of dermatological disorders in human beings |
| 12/23/2009 | EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy |